via provenge.com
The Centers for Medicare and Medicaid Services proposed paying for the vaccine, known as Provenge, which costs $93000 a patient. It had to go through further review (due to the expensive cost), which was unique. Usually a drug approved by the FDA is always paid for its indicated use by Medicare.
